Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology
Ketamine is a general anesthetic that is used also as an anti-depressant, but its use is associated with cystitis. Here, the authors show that ketamine is an antagonist of the Cav1.2 channel in bladder smooth muscle cells, that ablation of this channel in mice mimics the cystitis induced by ketamine...
Main Authors: | Huan Chen, David H. Vandorpe, Xiang Xie, Seth L. Alper, Mark L. Zeidel, Weiqun Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-18167-4 |
Similar Items
-
Allicin disrupts cardiac Cav1.2 channels via trafficking
by: Dan Han, et al.
Published: (2019-01-01) -
CaVβ-subunit dependence of forward and reverse trafficking of CaV1.2 calcium channels
by: Ferron, L., et al.
Published: (2022) -
L-type CaV1.2 deletion in the cochlea but not in the brainstem reduces noise vulnerability: implication for CaV1.2 mediated control of cochlear BDNF expression
by: Annalisa eZuccotti, et al.
Published: (2013-08-01) -
Cellular expression profile for interstitial cells of cajal in bladder - a cell often misidentified as myocyte or myofibroblast.
by: Weiqun Yu, et al.
Published: (2012-01-01) -
Ketamine disrupts neuromodulatory control of glutamatergic synaptic transmission.
by: Gyorgy Lur, et al.
Published: (2019-01-01)